1. Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services

   • W. F. Lems
   • J. Paccou
   • International Osteoporosis Foundation Fracture Working Group

   Position Paper Open access 21 January 2021 Pages: 399 - 411

   

2. Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials

   • D. Rosenberg
   • T. Avni
   • T. Diker-Cohen

   Review 03 November 2020 Pages: 413 - 424

   

3. C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches

   • H. Mun
   • B. Liu
   • Q. Wu

   Original Article 15 September 2020 Pages: 425 - 435

   

4. Comparing three machine learning approaches to design a risk assessment tool for future fractures: predicting a subsequent major osteoporotic fracture in fracture patients with osteopenia and osteoporosis

   • B. C. S. de Vries
   • J. H. Hegeman
   • C. G. M. Groothuis-Oudshoorn

   Original Article 07 January 2021 Pages: 437 - 449

   

5. Exploring thoracic kyphosis and incident fracture from vertebral morphology with high-intensity exercise in middle-aged and older men with osteopenia and osteoporosis: a secondary analysis of the LIFTMOR-M trial

   • A. T. Harding
   • B. K. Weeks
   • B. R. Beck

   Original Article 15 September 2020 Pages: 451 - 465

   

6. FRAX without BMD can be used to risk-stratify Veterans who recently sustained a low trauma non-vertebral/non-hip fracture

   • N. Sagalla
   • C. Colón-Emeric
   • R. Lee

   Original Article 04 September 2020 Pages: 467 - 472

   

7. Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients

   • L. Vehmanen
   • H. Sievänen
   • T. Saarto

   Original Article Open access 04 September 2020 Pages: 473 - 482

   

8. Defining an international cut-off of two-legged countermovement jump power for sarcopenia and dysmobility syndrome

   • N. Hong
   • E. Siglinsky
   • B. Buehring

   Original Article Open access 07 September 2020 Pages: 483 - 493

   

9. Efficiency of coordinator-based osteoporosis intervention in fragility fracture patients: a prospective randomized trial

   • M. Osaki
   • R. Okuda
   • H. Hagino

   Original Article Open access 23 January 2021 Pages: 495 - 503

   

10. Incidence and circumstances of falls among middle-aged women: a cohort study

    • M. Wang
    • F. Wu
    • T. Winzenberg

    Original Article 12 September 2020 Pages: 505 - 513

    

11. Sleep duration and bone health measures in older men

    • C. M. Swanson
    • P. J. Blatchford
    • for The Osteoporotic Fractures in Men (MrOS) Study

    Original Article 15 September 2020 Pages: 515 - 527

    

12. Psoriasis is associated with an increased risk of osteoporosis: follow-up and nested case–control studies using a national sample cohort

    • J.W. Lee
    • C. Min
    • H.G. Choi

    Original Article 05 November 2020 Pages: 529 - 538

    

13. Reference range for 24-h urine calcium, calcium/creatinine ratio, and correlations with calcium absorption and serum vitamin D metabolites in normal women

    • L. M. Smith
    • J. C. Gallagher

    Original Article 04 September 2020 Pages: 539 - 547

    

14. Functional electrical stimulation (FES)–assisted rowing combined with zoledronic acid, but not alone, preserves distal femur strength and stiffness in people with chronic spinal cord injury

    • Y. Fang
    • L.R. Morse
    • K.L. Troy

    Original Article 04 September 2020 Pages: 549 - 558

    

15. Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture

    • K. Zhu
    • J. Zhang
    • J. Guan

    Original Article 28 September 2020 Pages: 559 - 564

    

16. Comparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort study

    • A. R. Zullo
    • Y. Lee
    • S. D. Berry

    Original Article 07 January 2021 Pages: 565 - 573

    

17. Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling

    • R. Winzenrieth
    • M.S. Ominsky
    • R.J. Weiss

    Original Article Open access 26 January 2021 Pages: 575 - 583

    

18. Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden

    • E. Söreskog
    • I. Lindberg
    • F. Borgström

    Original Article Open access 06 January 2021 Pages: 585 - 594

    

19. Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy

    • M. Hiligsmann
    • S. Maggi
    • J.-Y. Reginster

    Original Article Open access 14 January 2021 Pages: 595 - 606

    

20. In memory of Harry K Genant

    • C. Cooper
    • P. Halbout
    • on behalf of the International Osteoporosis Foundation

    Obituary 26 January 2021 Pages: 607 - 608

    

21. Correction to: Real-world bone turnover marker use: impact on treatment decisions and fracture

    • N. E. Lane
    • K. Saag
    • R. Eastell

    Correction Open access 19 January 2021 Pages: 609 - 609